Skip to content

Efficacy of pregabalin in carpal tunnel syndrome

Effectiveness of pregabalin in treatment of carpal tunnel syndrome: A Randomized controlled trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/033084
Enrollment
130
Registered
2021-04-26
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G560- Carpal tunnel syndrome

Interventions

Intervention1: PREGABALIN: Capsule PREGABALIN 50 mg once daily for 1 week followed by twice daily for 1 week followed by thrice daily for another 6 weeks (total 8 weeks) Control Intervention1: PLACEBO

Sponsors

INSTITUTE OF MEDICAL SCIENCES BHU VARANASI
Lead Sponsor
La Renon Healthcare Pvt Ltd
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: patients with symptoms & signs of CTS(idiopathic) with at least one of the following electrophysiological features- A.Difference in Median and Ulnar sensory peak Latency >0.5ms B.Difference in Median and Ulnar motor distal latency >0.5ms C.Median sensory latency �3.6ms D.Median motor distal Latency �4.5ms

Exclusion criteria

Exclusion criteria: A.Severe CTS with thenar atrophy B.Previously operated for release of Carpal Tunnel or local steroid injection C.Secondary causes of CTS like Diabetes mellitus, rheumatoid arthritis, hypothyroidism, amyloidosis and post-traumatic D.Patients with other neurological causes like polyneuropathies, thoracic outlet syndrome, cervical radiculopathy E.Patients in whom ultrasound reveal secondary causes of carpal tunnel syndrome like Ganglion cysts, accessory muscles etc F.Not willing to participate/give consent G.Pregnant or breast feeding women H. Clinically significant cardiovascular, renal or hepatic disease I. Patients on pregabalin for other casuse like seizure disorder, trigeminal neuralgia

Design outcomes

Primary

MeasureTime frame
Change in BCTQ(Boston Carpal Tunnel Questionnaire) subscale score A. SSS(Symptom Severity Score) B. FSS(Functional Status Score)Timepoint: baseline,2 weeks,8 weeks

Secondary

MeasureTime frame
Change in clinical grading of CTSTimepoint: Baseline, 8 week;Change in Electro-physiological grading of CTSTimepoint: Baseline, 8 week;Change in grip strength by hydraulic hand dynamometerTimepoint: Baseline, 2 week, 8 week

Countries

India

Contacts

Public ContactDR KUMAR BISMAYA

INSTITUTE IF MEDICAL SCIENCE,BHU

goforrameshwar@gmail.com9415353255

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026